---
title: "The Nasdaq Biotechnology Index closed up over 2%"
description: "The Nasdaq Biotechnology Index rose by more than 2%. Oric Pharma increased by 33.50%, Erasca rose by 32.73%, and Tango Therapeutics climbed by 20.10%. Lexicon Pharmaceuticals (LXRX) fell by 5.66%, Rap"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/242464376.md"
published_at: "2025-05-29T20:44:12.000Z"
---

# The Nasdaq Biotechnology Index closed up over 2%

> The Nasdaq Biotechnology Index rose by more than 2%. Oric Pharma increased by 33.50%, Erasca rose by 32.73%, and Tango Therapeutics climbed by 20.10%. Lexicon Pharmaceuticals (LXRX) fell by 5.66%, Rapport Therapeutics dropped by 10.46%, and Intellia Therapeutics decreased by 22.88%

Component stock Oric Pharma rose by 33.50%, Erasca rose by 32.73%, and Tango Therapeutics rose by 20.10%, ranking third. LXRX (Laiskan Pharmaceutical) fell by 5.66%, ranking third in decline, Rapport Therapeutics fell by 10.46%, and Intellia Therapeutics also fell by 22.88%

### Related Stocks

- [ERAS.US - Erasca](https://longbridge.com/en/quote/ERAS.US.md)
- [TNGX.US - Tango Therapeutics](https://longbridge.com/en/quote/TNGX.US.md)
- [LXRX.US - Lexicon Pharma](https://longbridge.com/en/quote/LXRX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Pivotal Vopimetostat Pancreatic Cancer Trial Plan Might Change The Case For Investing In Tango Therapeutics (TNGX) | Tango Therapeutics, Inc. is advancing vopimetostat into a pivotal 300-patient trial for second-line pancreatic cancer, f | [Link](https://longbridge.com/en/news/276141096.md) |
| Tango Therapeutics CEO Teases Pivotal Vopimetostat Trial, RAS Combo Data at Guggenheim Chat | Tango Therapeutics (NASDAQ:TNGX) is advancing its PRMT5 inhibitor vopimetostat into late-stage development, as announced | [Link](https://longbridge.com/en/news/276011306.md) |
| Erasca Touts Early ERAS-0015 Responses, Potency Edge in Guggenheim Fireside Chat | Erasca (NASDAQ:ERAS) executives discussed early clinical signals and their RAS-focused pipeline during a Guggenheim fire | [Link](https://longbridge.com/en/news/275937678.md) |
| Tango Therapeutics CFO Daniella Beckman Reports Disposal of Common Shares | Daniella Beckman, CFO of Tango Therapeutics Inc., reported the disposal of common shares of the company. The full filing | [Link](https://longbridge.com/en/news/274893551.md) |
| Erasca Inc. General Counsel Ebun Garner Reports Disposal of Common Shares | Ebun Garner, General Counsel & Corporate Secretary of Erasca Inc., reported the disposal of common shares of the company | [Link](https://longbridge.com/en/news/272012485.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.